Aehr Test Systems — Q3 FY2024 Form 10-Q
Reporting period: Three and nine months ended February 29, 2024; comparisons are to the periods ended February 28, 2023. Aehr develops and manufactures semiconductor test and burn-in equipment. Financial amounts below are in U.S. dollars; “$ million” is used for readability.
Financial performance
| Metric | Q3 FY2024 | Q3 FY2023 | Nine months FY2024 | Nine months FY2023 |
|---|---|---|---|---|
| Revenue | $7.6m | $17.2m | $49.6m | $42.7m |
| Gross profit / margin | $3.2m / 41.7% | $8.9m / 51.6% | $24.1m / 48.6% | $21.3m / 49.8% |
| Operating income (loss) | $(2.0)m | $3.8m | $7.5m | $7.7m |
| Net income (loss) | $(1.5)m | $4.1m | $9.3m | $8.4m |
| Diluted EPS | $(0.05) | $0.14 | $0.31 | $0.29 |
- Quarterly revenue fell 56%, primarily as shipments declined amid softness in electric-vehicle demand. Systems revenue decreased $7.8m, contactors $1.5m, and services $0.3m year over year.
- Nine-month revenue grew 16%, led by an $11.8m increase in contactor sales; systems revenue declined $5.6m. Contactors generated $25.2m of nine-month revenue versus $13.4m a year earlier.
- Quarterly gross margin declined 9.9 percentage points, attributed to lower shipment volumes and manufacturing efficiency, design-change costs, and higher warranty expense. Nine-month margin declined 1.2 points, reflecting product cost pressure partly offset by improved services margin.
- Quarterly operating expenses were $5.2m, including $2.1m R&D and $3.1m SG&A. Nine-month operating expenses rose to $16.6m from $13.5m, with higher R&D and employment-related costs.
Cash, liquidity, and balance sheet
- At February 29, 2024, cash and cash equivalents were $47.6m; cash, cash equivalents, and restricted cash totaled $47.7m. Short-term investments were zero, following maturities during the period.
- Current assets were $92.3m and current liabilities $9.2m. Total liabilities were $15.1m, including operating lease liabilities; the filing reports no outstanding borrowings. The SVB revolving credit line was terminated January 4, 2024.
- Inventory increased to $38.1m from $23.9m at May 31, 2023, principally in raw materials and work in process. Accounts receivable declined to $5.5m from $16.6m.
- For the nine months, operating cash flow was $0.5m versus $4.1m. Inventory production and vendor payments used cash, partly offset by collections of receivables. Investing activities provided $17.3m, primarily reflecting investment maturities; financing used $0.3m.
- Management stated existing cash resources and anticipated operating funds should meet operating, capital expenditure, and other cash needs for the next 12 months.
Changes, outlook, and risks
- Quarterly results reversed from profit to loss as revenue contracted sharply; nine-month revenue and net income remained above the prior-year levels.
- Revenue concentration is substantial: Customer A represented 59.6% of quarterly and 65.8% of nine-month revenue; Customer B represented 19.3% of quarterly revenue. Customer A was 70.2% of gross receivables at quarter-end.
- Asia represented 68.3% of quarterly revenue and 87.3% of nine-month revenue. Management linked the quarterly decline in Asia and U.S. shipments to EV-demand softness.
- No specific revenue or earnings guidance was provided. Management noted R&D spending may fluctuate with product-development timing and revenue needs.
- Purchase commitments include some non-cancelable supplier orders for unique products. The company also has ordinary-course customer and officer/director indemnities; maximum exposure is not quantifiable from the filing. Management did not expect pending legal matters to have a material effect, and reported no material legal proceedings or accrued litigation loss.
- Management reported disclosure controls were effective and no material changes to internal control over financial reporting. It stated there had been no subsequent material changes to the risks in the FY2023 Form 10-K.
Important facts for investors to verify
- Whether EV-related demand softness persists and how it affects system shipments, revenue, and manufacturing utilization.
- Customer concentration, particularly Customer A’s share of revenue and receivables, and the timing and collectability of customer orders.
- Whether elevated inventory converts to shipments without additional write-downs, and whether design-change and warranty costs moderate.
- Future cash generation after the quarter’s low operating cash flow, including the impact of inventory investment and the absence of a revolving credit line.
- Share issuance and dilution: common shares outstanding were 28.906m at February 29, 2024 and 28.915m as of April 1, 2024.